Sarah Cannon Research Institute/Tennesse Oncology

Nashville, Tennessee 37203

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Sarah Cannon Research Institute/Tennesse Oncology
mi
from
Nashville, TN
Click here to add this to my saved trials